Teva Pharmaceutical reported 1.92B in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aspen Pharmacare APN:SJ 9.19B 478M
Cipla CIPLA:IN 34.36B 6.51B
Dr.Reddys Laboratories DRRD:IN 32.43B 163M
Guangzhou Baiy 600332:CH 2.96B 1.44B
Jiangsu Hengrui Me. 600276:CH CH 5.48B 484.75M
Kalbe Farma Tbk Pt KLBF:IJ 2750.16B 102.97B
Richter Gedeon RICHT:HB 88.23B 10.02B
Sh Fosun Pharma 600196:CH CH 4.55B 374.85M
Sun Pharmaceuticals SUNP:IN IR 70693.1M 7870.9M
Teva Pharmaceutical TEVA:IT 1.92B 4M